Although anti PD–1 treatment alone have so far not been effective [8], It is still important to characterize the expression of PDL1 and PDL2 on subsets of leukocytes to verify whether there are differences between myeloma patients. This evidence concerns the gene PDCD1 and plasma cell myeloma.